Five individuals and their company, NHS Systems, Inc., have been banned from telemarketing, charging consumers’ bank accounts, and making false and misleading statements.
The judgment, entered by U.S. District Court Judge Juan R. Sánchez at the request of the Federal Trade Commission (FTC), also requires them to pay almost $6.9 million -- the amount their scheme took from defrauded consumers.
“All defendants have acted with reckless disregard for the financial interest and security of thousands of consumers,” according to Judge Sánchez. “They have demonstrated their continued ability, desire, and success in committing the same deceptive acts. The danger of recurrent violations is real.”
Operation Tele-PHONEY
The FTC filed its complaint as part of ‘Operation Tele-PHONEY,’ a 2008 crackdown on deceptive telemarketing. An amended complaint filed in 2009 accused the defendants of using third-party telemarketers to unfairly and deceptively market and charge consumers for one or more discount health programs.
The telemarketers allegedly led consumers to believe they were from, or affiliated with, U.S. government agencies, including the Social Security Administration, the Internal Revenue Service, and Medicare, the complaint states. Consumers were told that they would receive substantial deposits into their bank accounts -- in the form of grants, tax refunds, or tax rebates -- if they first provided their account or credit card information. In many instances, the callers told consumers that they had been unconditionally selected.
Medicare scam
Medicare beneficiaries were told, in some cases, that they had to provide their financial information to continue receiving their benefits. In other cases, the defendants charged consumers’ financial accounts without any notice and without their authorization.
Consumers often were charged $29.95 to receive health care information, $299.95 to enroll in the program, and $19.95 per month thereafter, finding themselves in a “discount health care program” they never agreed to purchase.
The court found that the conduct of the NHS defendants, was unfair, as it “caused and was likely to cause substantial financial injury to the consumers.” It also determined their conduct was deceptive and that the telemarketers made the alleged misrepresentations to consumers, in violation of the FTC Act.
Numerous violations
Finally, the court ruled that the defendants violated several provisions of the FTC's Telemarketing Sales Rule (TSR) by:
- misrepresenting the total cost of the programs;
- overcharging consumers;
- charging consumers who were not enrolled in the healthcare program;
- charging consumers to enroll in what was supposed to be a free program;
- misrepresenting aspects of goods and services sold; and
- using audio authorizations that did not comply with the Rule.